Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 34Ovarian Neoplasms 31Peritoneal Neoplasms 28Fallopian Tube Neoplasms 14Colorectal Neoplasms 14Carcinoma, Ovarian Epithelial 13Appendiceal Neoplasms 7Neoplasm Metastasis 5Pancreatic Neoplasms 4Uterine Neoplasms 3Recurrence 3Pseudomyxoma Peritonei 3Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Sarcoma 2Peritoneal Diseases 2Mesothelioma, Malignant 2Mesothelioma 2Hyperthermic Intraperitoneal Chemotherapy 2Gastrointestinal Neoplasms 2Gastric Adenocarcinoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Wilms Tumor 1Stomach Diseases 1Stage â…¢ Gastric Cancer 1Stage IV Gastric Cancer With Metastasis 1Rhabdomyosarcoma 1Rectal Neoplasms 1

Interventions

camrelizumab 4Oxaliplatin 3apatinib 2S 1 (combination) 2Capecitabine 2XELOX 1Taxes 1Surgical Procedures, Operative 1Nivolumab 1Laparoscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrectomy 1Conversion to Open Surgery 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Gastric Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡